Alcohol Use Disorder and Cannabis: Testing Novel Harm Reduction Strategies
This is a double-blind, placebo-controlled, parallel group study designed to assess the efficacy of full spectrum CBD and broad spectrum CBD, compared to a placebo control (PC), to reduce drinking in participants with alcohol use disorder. If eligible for the study, subjects will be randomized to receive one of the conditions for 12 weeks.
If eligible for the study, subjects will be randomized to receive one of the conditions for 12 weeks
Adult
Treatment
Local
Outpatient CTRC
University of Colorado Hospital
Kent Hutchison, PhD
Protocol Number: 22-1894
More information available at ClinicalTrials.gov: NCT05613608
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers